Dose of Trimethoprim-Sulfamethoxazole To Treat Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus

We undertook this study to investigate whether treatment with a higher dose of trimethoprim-sulfamethoxazole (TMP/SMX) led to greater clinical resolution in patients with skin and soft tissue infections (SSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA). A prospective, observationa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cadena, Jose, Nair, Shalini, Henao-Martinez, Andres F., Jorgensen, James H., Patterson, Jan E., Sreeramoju, Pranavi V.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2011
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232808/
https://ncbi.nlm.nih.gov/pubmed/21930870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00706-11
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires